Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,659 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome.
Jain P, Keating M, Thompson PA, Trinh L, Wang X, Wierda W, Ferrajoli A, Burger J, Kantarjian H, Estrov Z, Abruzzo L, O'Brien S. Jain P, et al. Among authors: thompson pa. Am J Hematol. 2015 Jun;90(6):471-7. doi: 10.1002/ajh.23978. Epub 2015 Mar 30. Am J Hematol. 2015. PMID: 25683856 Free PMC article.
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
Chihara D, Kantarjian H, O'Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Poku R, Jain P, Thompson P, Brandt M, Luthra R, Burger J, Keating M, Ravandi F. Chihara D, et al. Among authors: thompson p. Br J Haematol. 2016 Sep;174(5):760-6. doi: 10.1111/bjh.14129. Epub 2016 Jun 15. Br J Haematol. 2016. PMID: 27301277 Free PMC article. Clinical Trial.
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.
Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z. Jain P, et al. Among authors: thompson p. Lancet Haematol. 2017 Feb;4(2):e67-e74. doi: 10.1016/S2352-3026(16)30194-6. Epub 2017 Jan 12. Lancet Haematol. 2017. PMID: 28089238 Free PMC article. Clinical Trial.
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. Shaim H, et al. Among authors: thompson pa. Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017. Front Immunol. 2018. PMID: 29379494 Free PMC article.
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.
Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: thompson p. Leuk Lymphoma. 2018 Nov;59(11):2686-2691. doi: 10.1080/10428194.2018.1439167. Epub 2018 Feb 21. Leuk Lymphoma. 2018. PMID: 29465264 Free PMC article.
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.
Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Uziel O, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: thompson pa. J Immunol. 2019 Dec 1;203(11):3078-3085. doi: 10.4049/jimmunol.1900389. Epub 2019 Oct 23. J Immunol. 2019. PMID: 31645416 Free PMC article.
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells.
Rozovski U, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Veletic I, Ferrajoli A, Bose P, Thompson P, Jain N, Verstovsek S, Wierda W, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: thompson p. Oncotarget. 2021 Mar 2;12(5):401-411. doi: 10.18632/oncotarget.27884. eCollection 2021 Mar 2. Oncotarget. 2021. PMID: 33747356 Free PMC article.
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
Rozovski U, Veletic I, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Verstovsek S, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: thompson pa. J Immunol. 2022 Jun 15;208(12):2847-2855. doi: 10.4049/jimmunol.2101105. Epub 2022 May 20. J Immunol. 2022. PMID: 35595309 Free PMC article.
6,659 results